CTRI/2020/04/024543尚未招募4 期
An open label, phase IV, randomized clinical trial of ArnikaPlus Combo Pack on hair problems
Allen Laboratories Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Male and female participants in the age group of 18-40 years.
- •2.Participants willing to give informed consent.
- •3.Participants willing to comply with the study procedures.
- •4.Participants who are fit and no need any hospital administration.
- •5.Complaints for diffuse hair loss/ slow growth of hair.
- •6.Complaints for dandruff and lice.
- •7.Complaints for bad quality of hair (elasticity, strength, fragility, longevity, smoothness).
- •8.Complaints for fungal infection.
排除标准
- •1.History of systemic or cutaneous malignancy or lesions.
- •2.History of psoriasis, polycystic ovarian syndrome.
- •3.Advanced or poorly controlled thyroidisms, diabetes and anemia.
- •4.Unstable cardiovascular disease.
- •5.Clinically significant medical or psychiatric disease.
- •6.Evidence of immunocompromised state.
- •7.Serious local infection (e.g. cellulites, abscess) or systemic infection (e.g. pneumonia, septicemia) within six months prior to enrollment.
- •8.Pregnant and lactating women
研究者
相似试验
进行中（未招募）
1 期
Clinical trial to evaluate the effects of Fydrane® and standard protocol on ocular surface after cataract surgery.CataractsMedDRA version: 20.0 Level: PT Classification code 10007739 Term: Cataract System Organ Class: 10015919 - Eye disordersMedDRA version: 20.0 Level: PT Classification code 10063797 Term: Cataract operation System Organ Class: 10042613 - Surgical and medical proceduresEUCTR2017-003277-34-ESaboratoires Théa50
已完成
4 期
RituxiMab in INDuction therapy for living donor renal transplantatioive donor renal transplantationSurgeryISRCTN95769119Guy's and St Thomas' Hospital NHS Foundation Trust (UK)316
招募中
4 期
A open label, phase IV clinical trial examining the efficacy of Prothrombinex alone verses Prothrombinex combined with fresh frozen plasma in patients who require Warfarin reversal.The efficacy to reverse the effect of warfarin by prothrombinex aloneBlood - Clotting disordersACTRN12607000567426Frankston Hospital40
进行中（未招募）
1 期
DETOX StudyHIVMedDRA version: 20.0Level: LLTClassification code 10001509Term: AIDSSystem Organ Class: 100000004862EUCTR2018-001158-82-ESFundación SEIMC-GESIDA110
进行中（未招募）
1 期
An open-label, randomized, Phase IV study, to assess the efficacy and safety of tildrakizumab in patients with moderate to severe chronic plaque psoriasis who are non-responders to dimethyl fumarate therapyEUCTR2019-000817-35-GBAlmirall250